Peanut Allergy Immunotherapy

Slides:



Advertisements
Similar presentations
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.
Advertisements

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
New Horizons for SMA.
Evolution of Treatment Strategies Targeting IL-23 for Psoriasis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data.
Unraveling Clinical Developments in NASH
Improving Survival in Glioblastoma Multiforme
Updates on Emerging GLP-1 Receptor Agonists
Progression After Cancer Immunotherapy in Advanced NSCLC
Immune Reconstitution in MS:
The HCV Revolution: Are You and Your Practice Ready?
New Standards of Care in ALK-Translocated Advanced NSCLC
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.
Navigating the Data and Evolving Our Approach
Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma
Addressing Disease Burden in Asthma
The Evolving Role of Immunotherapy in NSCLC
Immunotherapy in Pancreatic Cancer: Thinking Outside the Box
Optimizing Management of Advanced Bladder Cancer
Addressing Challenges in Factor VIII Inhibitors in Children With Hemophilia.
Advanced Lung Cancers: What's on the Horizon?
Next-Gen Psoriasis Therapies:
Program Agenda. Advances in Peanut Allergy Immunotherapy: When Science Meets Technology.
The Future of House Dust Mite Allergy
Evaluating Next-Generation BTK Inhibitors
Hyperhidrosis Is Burdensome!
Advances in Peanut Allergen Immunotherapy
Navigating New Oral Treatment Algorithms in CLL
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
Ask the Experts.
Immunotherapy for cSCC
Advancing Care in Genitourinary Cancer: Perspectives From Chicago
How to Effectively Manage Patients With Cutaneous Squamous Cell Carcinoma.
New Data on Emerging Treatments for Psoriasis
Advancing Care Across the Spectrum of Pancreatic Cancer
Personalizing Management in the Care of Patients With Advanced Sarcoma
Evolving Concepts in the Management of Head and Neck Cancers
Future Directions in Myelofibrosis: Implications of Emerging Approaches.
Advances in Peanut Allergy
Updates in the Management of Acute Promyelocytic Leukemia
Advances in Immunotherapy for Peanut Allergy
Immune Checkpoint Inhibitors in Lung Cancer
Expert Perspectives on New Data in Multiple Sclerosis From the 2018 European MS Meeting.
Locally Advanced Lung Cancer
Guide to Atopic Dermatitis
Peanut Allergy.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Patient Questions and Expert Answers in Psoriasis:
Biomarker Testing: Harnessing All Sides of the Tumor Microenvironment
Managing CLL With BTK Inhibitors
This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.
Novel Concepts in the Management of RCC
Debates and Dilemmas, Part 1
The ABCs of Pharmacogenomics in Clinical Practice
Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC
Prioritizing Prevention of HPV-Related Disease
Case Studies in Locally Advanced Pancreatic Cancer
Peanut Allergy Immunotherapy
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
Checkpoint Inhibitors in First-Line Advanced NSCLC
Peanut Allergy Immunotherapy
Going Beyond EXTREME in Head and Neck Cancer
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Pathophysiologic Targets of Allergic Asthma
Case Studies in Peanut Allergy Immunotherapy
Immune Checkpoint Inhibitors in Lung Cancer
Comparative Studies of Biologics in Ulcerative Colitis
Meet the JAKs.
Presentation transcript:

Peanut Allergy Immunotherapy

This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

Peanut Allergy

Efficacy vs Effectiveness

Real Life Example Liver Cancer Screening

Comparative Effectiveness Research

Translating Clinical Trial Data Into Practice CER

Steps Towards Effectiveness

Challenges Translating Efficacy Into Clinical Practice

Peanut Allergy Immunotherapy Trials

PALISADE Phase 3 Trial Trial Design

PALISADES Phase 3 Trial Efficacy: ITT Population

PALISADES Phase 3 Trial Safety Results

PALISADES Phase 3 Trial Safety Results (cont)

PALASIDES Trial Data Impact on Everyday Practice

Theoretical Modeling Examining Contamination of Peanuts in Packaged Goods and Reaction Risk

Theoretical Modeling Risk Reduction of Reactivity to Peanut

EPIT

PEPITES Trial Design

PEPITES Trial Results

PEPITES Trial Safety Results

Faculty Impressions of Immunotherapy Trials

Risk Reduction of Allergic Reactions After EPIT

Concluding Remarks

Abbreviations